Factor VIII - Guangdong Weilun Biological
Latest Information Update: 19 Nov 2021
At a glance
- Originator Guangdong Weilun Biological
- Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Haemophilia
Most Recent Events
- 29 Jul 2016 Investigation in Haemophilia in China (Parenteral)